thing line given new ai aided candidates animal testing stage drug development let human trials jury ai successfully drug discovery efficient says sara kenkare mitra senior vice president development sciences roche subsidiary genentech not incremental improvement exponential leap drugs result ai efforts human testing question not answered fully drugs progress way fda approval bristol myers squibb saha suggests ai aided drugs rate entry market likely remain low time rate pick dramatically processes testing approval streamlined account ability machine- deep learning systems accurately predict drugs highly likely safe effective patients best suited regulatory agencies value ai floodgates open says cases allowed